Skip to main content
. 2024 May 24;19(5):e0302657. doi: 10.1371/journal.pone.0302657

Table 2. Changes in body weight treated with S. heteromalla CME for seven days.

(A) Body Weight (Mean ± SEM) (Treated with S. heteromalla)
Dose (mg/kg) b.w Group-I
(Control)
Group-II
(500 mg)
Group-III
(1000 mg)
Group-IV
(2000 mg)
Group-V
(3000 mg)
Weight (g) before drug 31.4 ± 0.25 31.30 ± 0.25 31.7± 0.28 31.2 ± 0.25 31.8 ± 0.17
Weight (g) after drug 31.6 ± 0.010 31.8 ± 0.010 31.2 ± 0.010 26.58± 0.023 25.7 ± 0.011
(B) Dose Vs mortality and LD50 value of S. heteromalla CME
Dose (mg/kg) b.w Group-I
Normal saline
Group-II
(500 mg)
Group-III
(1000 mg)
Group-IV
(2000 mg)
Group-V
(3000 mg)
No of animals 6 6 6 6 6
Death /Mortality 0 0 0 6 6
LD50 = 1500 mg/kg
ED50(max) = 1000 mg/kg

p <0.05 (S), Values are expressed as ± SEM (standard error of mean), S = significant. B.w: body weight.